UnfairGaps
🇩🇪Germany

Unzureichende Rückrufverfolgung und verzögerte Produktrückverfolgung bei Serialisierungsfehlern

3 verified sources

Definition

Product recalls require rapid identification of affected batches and transaction history (which wholesaler received which lots, which pharmacies distributed which serials). Manual retrieval of transaction history from distributed systems creates delays, incomplete recall execution, and extended liability windows. Additionally, counterfeit product detection (lack of barcode match in DSCSA database) risks go unidentified until pharmacy-level verification.

Key Findings

  • Financial Impact: €50,000–€500,000 per recall incident (estimated: delayed recall costs €100/case × 500–5,000 cases unaccounted for; customer compensation €1,000–€10,000 per pharmacy for disrupted supply; liability exposure for contaminated or counterfeit product distribution).
  • Frequency: Incident-based (triggered by manufacturing defects, contamination, or counterfeit detection); industry average 5–15 recalls per year per major wholesaler.
  • Root Cause: Manual transaction history compilation; lack of automated product tracing across supply chain network; delayed identification of suspect/illegitimate products at dispensing point.

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Wholesale Drugs and Sundries.

Affected Stakeholders

Quality assurance and regulatory affairs, Supply chain and logistics management, Recall coordinators, Customer service and pharmacy liaisons

Action Plan

Run AI-powered research on this problem. Each action generates a detailed report with sources.

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Related Business Risks